Chronic Myelomonocytic Leukemia — Trials

Chronic Myelomonocytic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

292 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 86
Recruiting: 51
Ph III recruiting: 3
Growth YoY: —
Industry share: 19%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 25.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (43)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03964506	Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant	recruiting	Early Phase 1	24	Omar AljitawiOTHER	1	Jun 3, 2026	clinicaltrials
NCT07071155	Momelotinib in Combination With Hypomethylating Agent for Chronic Phase Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Chronic Neutrophilic Leukemia(M-HArbOr)	recruiting	Early Phase 1	18	Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER	1